These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21695548)

  • 21. Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators.
    Martin FL; Chen HH; Cataliotti A; Burnett JC
    Rev Cardiovasc Med; 2008; 9(1):39-45. PubMed ID: 18418308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure.
    de Silva R; Nikitin NP; Witte KK; Rigby AS; Loh H; Nicholson A; Bhandari S; Clark AL; Cleland JG
    Eur J Heart Fail; 2007 Apr; 9(4):415-23. PubMed ID: 17174600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal and cardiac function during alpha1-beta-blockade in congestive heart failure.
    Heitmann M; Davidsen U; Stokholm KH; Rasmussen K; Burchardt H; Petersen EB
    Scand J Clin Lab Invest; 2002; 62(2):97-104. PubMed ID: 12004934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diuretic therapy in congestive heart failure for the elderly patient.
    Carvalho Filho ET
    Drugs; 1986; 31 Suppl 4():165-73. PubMed ID: 3732094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis.
    de Silva R; Nikitin NP; Witte KK; Rigby AS; Goode K; Bhandari S; Clark AL; Cleland JG
    Eur Heart J; 2006 Mar; 27(5):569-81. PubMed ID: 16364971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease.
    Fröhlich H; Nelges C; Täger T; Schwenger V; Cebola R; Schnorbach J; Goode KM; Kazmi S; Katus HA; Cleland JG; Clark AL; Frankenstein L
    Am Heart J; 2016 Aug; 178():28-36. PubMed ID: 27502849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diastolic dysfunction in congestive heart failure.
    Johnson JA
    Clin Pharm; 1991 Nov; 10(11):850-61. PubMed ID: 1794221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical management of chronic heart failure in children.
    Ross RD
    Am J Cardiovasc Drugs; 2001; 1(1):37-44. PubMed ID: 14728050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of renal function during and after an episode of cardiac decompensation: results from the Italian survey on acute heart failure.
    Tarantini L; Cioffi G; Gonzini L; Oliva F; Lucci D; Di Tano G; Maggioni AP; Tavazzi L;
    J Cardiovasc Med (Hagerstown); 2010 Apr; 11(4):234-43. PubMed ID: 19858732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction. II. Diuretics.
    Fortuna P; Reis I; Ascenção R; Carneiro AV
    Rev Port Cardiol; 2008; 27(7-8):977-89. PubMed ID: 18959094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis.
    Cleland JG; Carubelli V; Castiello T; Yassin A; Pellicori P; Antony R
    Heart Fail Rev; 2012 Mar; 17(2):133-49. PubMed ID: 22426973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure.
    Weinfeld MS; Chertow GM; Stevenson LW
    Am Heart J; 1999 Aug; 138(2 Pt 1):285-90. PubMed ID: 10426840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardio-renal interaction: impact of renal function and anemia on the outcome of chronic heart failure.
    Kimura H; Hiramitsu S; Miyagishima K; Mori K; Yoda R; Kato S; Kato Y; Morimoto S; Hishida H; Ozaki Y
    Heart Vessels; 2010 Jul; 25(4):306-12. PubMed ID: 20676839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The care for chronic heart failure by general practitioners. Results from a clinical audit in Italy.
    Cancian M; Battaggia A; Celebrano M; Del Zotti F; Novelletto BF; Michieli R; Saugo M; Pellizzari M; Toffanin R
    Eur J Gen Pract; 2013 Mar; 19(1):3-10. PubMed ID: 22998169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Change in renal function associated with drug treatment in heart failure: national guidance.
    Clark AL; Kalra PR; Petrie MC; Mark PB; Tomlinson LA; Tomson CR
    Heart; 2019 Jun; 105(12):904-910. PubMed ID: 31118203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin-converting enzyme inhibitors and receptor blockers in heart failure and chronic kidney disease - Demystifying controversies.
    Muneer K; Nair A
    Indian Heart J; 2017; 69(3):371-374. PubMed ID: 28648436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment.
    Carubelli V; Metra M; Lombardi C; Bettari L; Bugatti S; Lazzarini V; Dei Cas L
    Heart Fail Rev; 2012 Mar; 17(2):271-82. PubMed ID: 21748453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The renal artery resistive index is an integral marker of renal dysfunction in patients with chronic heart failure].
    Kovaleva IuV; Kirichenko AA
    Vestn Rentgenol Radiol; 2012; (4):15-20. PubMed ID: 23214025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights into the contemporary epidemiology and outpatient management of congestive heart failure.
    McAlister FA; Teo KK; Taher M; Montague TJ; Humen D; Cheung L; Kiaii M; Yim R; Armstrong PW
    Am Heart J; 1999 Jul; 138(1 Pt 1):87-94. PubMed ID: 10385769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.